Manufacturers report that they are experiencing unprecedented business conditions. Demand for any product with a potential immunity tie in has spiked. Some companies, like NOW, based in Bloomingdale, IL, have responded by putting on mandatory overtime shifts in an effort to keep out of stocks to a minimum.
New research supports category
While tens of thousands of new consumers, spurred by their search for solutions to their pandemic fears, come into the supplement category, the crisis is causing new research to pile up as well. Recent research published as an opinion piece in the Journal of Alimentary Pharmacology and Therapeutics shows what the authors see as a ‘clear link’ between higher vitamin D status and better outcomes from instances of COVID-19 disease. As consumers digest that information they may also come across recent research on vitamin D’s benefits in bone health and a lower risk of dying from cancer.
Similarly, a recent study using the data from blood draws of COVID-19 patients in the Netherlands has shown that patients with a higher vitamin K2 status had significantly better outcomes from their infections. Fewer of them required intubation, and fewer of them died.
The research behind this vitamin and it’s effects on bone health as well as cardiovascular disease is becoming so compelling that one of the major suppliers, Norwegian company Nattopharma, is working toward official recognition in the form of an RDI for the substance.
For probiotics, the research has become compelling enough on these ingredients’s effects on supporting immune function and reducing the severity of respiratory infections to enable the International Society of Sports Nutrition to put out a position paper on the subject. Athletes, who can compromise their immune systems as they train for and compete in high stress, long term events, can benefit from using these supplements, the paper says.